| 臺大學術典藏 |
2021-01-28T01:06:23Z |
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
|
Liang Y.-H.;Wei C.-H.;Hsu W.-H.;Shao Y.-Y.;Lin Y.-C.;Chou P.-C.;Cheng A.-L.;Kun-Huei Yeh; Liang Y.-H.; Wei C.-H.; Hsu W.-H.; Shao Y.-Y.; Lin Y.-C.; Chou P.-C.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:23Z |
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study
|
Cheng A.-L.;Cornelio G.;Shen L.;Price T.;Yang T.-S.;Chung I.J.;Dai G.-H.;Lin J.-K.;Sharma A.;Kun-Huei Yeh;Ma B.;Zaatar A.;Guan Z.;Masood N.;Srimuninnimit V.;Yau T.;Gibbs P.;Wang X.;Doval D.C.;Oh S.-T.;Shim B.Y.;Gorospe C.;Wang H.-M.;Sirachainan E.;Hill A.;Suh K.W.;Beier F.;Chatterjee S.;Lim R.; Cheng A.-L.; Cornelio G.; Shen L.; Price T.; Yang T.-S.; Chung I.J.; Dai G.-H.; Lin J.-K.; Sharma A.; KUN-HUEI YEH; Ma B.; Zaatar A.; Guan Z.; Masood N.; Srimuninnimit V.; Yau T.; Gibbs P.; Wang X.; Doval D.C.; Oh S.-T.; Shim B.Y.; Gorospe C.; Wang H.-M.; Sirachainan E.; Hill A.; Suh K.W.; Beier F.; Chatterjee S.; Lim R. |
| 臺大學術典藏 |
2021-01-28T01:06:22Z |
Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis
|
Guo J.-C.;Chang C.-C.;Yang C.-Y.;Liao B.-C.;Liau J.-Y.;Chang C.-H.;Kun-Huei Yeh; Guo J.-C.; Chang C.-C.; Yang C.-Y.; Liao B.-C.; Liau J.-Y.; Chang C.-H.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:22Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.;Lee J.-C.;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:22Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.;Kun-Huei Yeh;Wu M.-S.;Lin C.-W.;Wei M.-F.;Liou J.-M.;Wang H.-P.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; KUN-HUEI YEH; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:21Z |
Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinoma
|
Javle M.;Lowery M.;Shroff R.T.;Weiss K.H.;Springfeld C.;Borad M.J.;Ramanathan R.K.;Goyal L.;Sadeghi S.;Macarulla T.;El-Khoueiry A.;Kelley R.K.;Borbath I.;Choo S.P.;Oh D.-Y.;Philip P.A.;Chen L.-T.;Reungwetwattana T.;Van Cutsem E.;Kun-Huei Yeh;Ciombor K.;Finn R.S.;Patel A.;Sen S.;Porter D.;Isaacs R.;Zhu A.X.;Abou-Alfa G.K.;Bekaii-Saab T.; Javle M.; Lowery M.; Shroff R.T.; Weiss K.H.; Springfeld C.; Borad M.J.; Ramanathan R.K.; Goyal L.; Sadeghi S.; Macarulla T.; El-Khoueiry A.; Kelley R.K.; Borbath I.; Choo S.P.; Oh D.-Y.; Philip P.A.; Chen L.-T.; Reungwetwattana T.; Van Cutsem E.; KUN-HUEI YEH; Ciombor K.; Finn R.S.; Patel A.; Sen S.; Porter D.; Isaacs R.; Zhu A.X.; Abou-Alfa G.K.; Bekaii-Saab T. |
| 臺大學術典藏 |
2021-01-28T01:06:21Z |
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: A JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
|
Yoshino T.;Arnold D.;Taniguchi H.;Pentheroudakis G.;Yamazaki K.;Xu R.-H.;Kim T.W.;Ismail F.;Tan I.B.;Kun-Huei Yeh;Grothey A.;Zhang S.;Ahn J.B.;Mastura M.Y.;Chong D.;Chen L.-T.;Kopetz S.;Eguchi-Nakajima T.;Ebi H.;Ohtsu A.;Cervantes A.;Muro K.;Tabernero J.;Minami H.;Ciardiello F.;Douillard J.-Y.; Yoshino T.; Arnold D.; Taniguchi H.; Pentheroudakis G.; Yamazaki K.; Xu R.-H.; Kim T.W.; Ismail F.; Tan I.B.; KUN-HUEI YEH; Grothey A.; Zhang S.; Ahn J.B.; Mastura M.Y.; Chong D.; Chen L.-T.; Kopetz S.; Eguchi-Nakajima T.; Ebi H.; Ohtsu A.; Cervantes A.; Muro K.; Tabernero J.; Minami H.; Ciardiello F.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:21Z |
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Kang Y.-K.;Boku N.;Satoh T.;Ryu M.-H.;Chao Y.;Kato K.;Chung H.C.;Chen J.-S.;Muro K.;Kang W.K.;Kun-Huei Yeh;Yoshikawa T.;Oh S.C.;Bai L.-Y.;Tamura T.;Lee K.-W.;Hamamoto Y.;Kim J.G.;Chin K.;Oh D.-Y.;Minashi K.;Cho J.Y.;Tsuda M.;Chen L.-T.; Kang Y.-K.; Boku N.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Chen L.-T. |
| 臺大學術典藏 |
2021-01-28T01:06:20Z |
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYnote-061): a randomised, open-label, controlled, phase 3 trial
|
Shitara K.;?Zg?Ro?Lu M.;Bang Y.-J.;Di Bartolomeo M.;Mandal? M.;Ryu M.-H.;Fornaro L.;Olesi?Ski T.;Caglevic C.;Chung H.C.;Muro K.;Goekkurt E.;Mansoor W.;Mcdermott R.S.;Shacham-Shmueli E.;Chen X.;Mayo C.;Kang S.P.;Ohtsu A.;Fuchs C.S.;Lerzo G.;O'Connor J.M.;Mendez G.A.;Lynam J.;Tebbutt N.;Wong M.;Strickland A.;Karapetis C.;Goldstein D.;Vasey P.;Van Laethem J.-L.;Van Cutsem E.;Berry S.;Vincent M.;Muller B.;Rey F.;Zambrano A.;Guerra J.;Krogh M.;Baeksgaard L.;Yilmaz M.;Elme A.;Magi A.;Auvinen P.;Alanko T.;Moehler M.;Kunzmann V.;Seufferlein T.;Thuss-Patience P.;Goekkurt E.;Hoehler T.;Haag G.;Al-Batran S.-E.;Castro H.;Lopez K.;Aguilar Vasquez M.;Sandoval M.;Lam K.O.;Cuffe S.;Kelly C.;Geva R.;Shacham-Shmueli E.;Hubert A.;Beny A.;Brenner B.;Giuseppe A.;Falcone A.;Maiello E.;Passalacqua R.;Montesarchio V.;Hara H.;Chin K.;Nishina T.;Komatsu Y.;Machida N.;Hironaka S.;Satoh T.;Tamura T.;Sugimoto N.;Cho H.;Omuro Y.;Kato K.;Goto M.;Hyodo I.;Yoshida K.;Baba H.;Esaki T.;Furuse J.;Wan Mohammed W.Z.;Hernandez Hernandez C.;Casas Garcia J.;Dominguez Andrade A.;Clarke K.;Hjortland G.;Glenjen N.;Kubiatowski T.;Jacek J.;Wojtukiewicz M.;Lazarev S.;Lancukhay Y.;Afanasayev S.;Moiseyenko V.;Kostorov V.;Protsenko S.;Shirinkin V.;Sakaeva D.;Fadeeva N.;Yong W.P.;Ng C.H.M.;Robertson B.;Rapaport B.;Cohen G.;Dreosti L.;Ruff P.;Jacobs C.;Landers G.;Szpak W.;Roh S.-Y.;Lee J.;Kim Y.H.;Bang Y.-J.;Chung H.C.;Ryu M.-H.;Alsina Maqueda M.;Longo Munoz F.;Cervantes Aguilar A.;Aranda Aguilar E.;Garcia Alfonso P.;Rivera F.;Feliu Batle J.;Pazo Cid R.;Kun-Huei Yeh;Chen J.-S.;Chao Y.;Yen C.-J.;?Zg?Ro?Lu M.;Kara O.;Yalcin S.;Hochhauser D.;Chau I.;Benson A.;Shankaran V.;Shaib W.;Philip P.;Sharma V.;Siegel R.;Sun W.;Wainberg Z.;George B.;Bullock A.;Myrick S.;Faruol J.;Siegel R.;Larson T.;Becerra C.;Ratnam S.;Richards D.A.;Riche S.L.;Keynote-061 Investigators; Shitara K.; ?zg?ro?lu M.; Bang Y.-J.; Di Bartolomeo M.; Mandal? M.; Ryu M.-H.; Fornaro L.; Olesi?ski T.; Caglevic C.; Chung H.C.; Muro K.; Goekkurt E.; Mansoor W.; McDermott R.S.; Shacham-Shmueli E.; Chen X.; Mayo C.; Kang S.P.; Ohtsu A.; Fuchs C.S.; Lerzo G.; O'Connor J.M.; Mendez G.A.; Lynam J.; Tebbutt N.; Wong M.; Strickland A.; Karapetis C.; Goldstein D.; Vasey P.; Van Laethem J.-L.; Van Cutsem E.; Berry S.; Vincent M.; Muller B.; Rey F.; Zambrano A.; Guerra J.; Krogh M.; Baeksgaard L.; Yilmaz M.; Elme A.; Magi A.; Auvinen P.; Alanko T.; Moehler M.; Kunzmann V.; Seufferlein T.; Thuss-Patience P.; Goekkurt E.; Hoehler T.; Haag G.; Al-Batran S.-E.; Castro H.; Lopez K.; Aguilar Vasquez M.; Sandoval M.; Lam K.O.; Cuffe S.; Kelly C.; Geva R.; Shacham-Shmueli E.; Hubert A.; Beny A.; Brenner B.; Giuseppe A.; Falcone A.; Maiello E.; Passalacqua R.; Montesarchio V.; Hara H.; Chin K.; Nishina T.; Komatsu Y.; Machida N.; Hironaka S.; Satoh T.; Tamura T.; Sugimoto N.; Cho H.; Omuro Y.; Kato K.; Goto M.; Hyodo I.; Yoshida K.; Baba H.; Esaki T.; Furuse J.; Wan Mohammed W.Z.; Hernandez Hernandez C.; Casas Garcia J.; Dominguez Andrade A.; Clarke K.; Hjortland G.; Glenjen N.; Kubiatowski T.; Jacek J.; Wojtukiewicz M.; Lazarev S.; Lancukhay Y.; Afanasayev S.; Moiseyenko V.; Kostorov V.; Protsenko S.; Shirinkin V.; Sakaeva D.; Fadeeva N.; Yong W.P.; Ng C.H.M.; Robertson B.; Rapaport B.; Cohen G.; Dreosti L.; Ruff P.; Jacobs C.; Landers G.; Szpak W.; Roh S.-Y.; Lee J.; Kim Y.H.; Bang Y.-J.; Chung H.C.; Ryu M.-H.; Alsina Maqueda M.; Longo Munoz F.; Cervantes Aguilar A.; Aranda Aguilar E.; Garcia Alfonso P.; Rivera F.; Feliu Batle J.; Pazo Cid R.; KUN-HUEI YEH; Chen J.-S.; Chao Y.; Yen C.-J.; ?zg?ro?lu M.; Kara O.; Yalcin S.; Hochhauser D.; Chau I.; Benson A.; Shankaran V.; Shaib W.; Philip P.; Sharma V.; Siegel R.; Sun W.; Wainberg Z.; George B.; Bullock A.; Myrick S.; Faruol J.; Siegel R.; Larson T.; Becerra C.; Ratnam S.; Richards D.A.; Riche S.L.; KEYnote-061 investigators |
| 臺大學術典藏 |
2021-01-28T01:06:20Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Kun-Huei Yeh;Hsu C.-H.;Lee J.-M.; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; KUN-HUEI YEH; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:19Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: A JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
|
Muro K.;Van Cutsem E.;Narita Y.;Pentheroudakis G.;Baba E.;Li J.;Ryu M.-H.;Wan Zamaniah W.I.;Yong W.-P.;Kun-Huei Yeh;Kato K.;Lu Z.;Cho B.C.;Nor I.M.;Ng M.;Chen L.-T.;Nakajima T.E.;Shitara K.;Kawakami H.;Tsushima T.;Yoshino T.;Lordick F.;Martinelli E.;Smyth E.C.;Arnold D.;Minami H.;Tabernero J.;Douillard J.-Y.; Muro K.; Van Cutsem E.; Narita Y.; Pentheroudakis G.; Baba E.; Li J.; Ryu M.-H.; Wan Zamaniah W.I.; Yong W.-P.; KUN-HUEI YEH; Kato K.; Lu Z.; Cho B.C.; Nor I.M.; Ng M.; Chen L.-T.; Nakajima T.E.; Shitara K.; Kawakami H.; Tsushima T.; Yoshino T.; Lordick F.; Martinelli E.; Smyth E.C.; Arnold D.; Minami H.; Tabernero J.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:19Z |
A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma
|
Yang S.-H.;Shao Y.-Y.;Lin C.-C.;Kuo S.-H.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:19Z |
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: A randomized Phase III study
|
Li J.;Xu R.;Qin S.;Liu T.;Pan H.;Xu J.;Bi F.;Lim R.;Zhang S.;Ba Y.;Bai Y.;Fan N.;Tsuji A.;Kun-Huei Yeh;Ma B.;Wei V.;Shi D.;Magherini E.;Shen L.; Li J.; Xu R.; Qin S.; Liu T.; Pan H.; Xu J.; Bi F.; Lim R.; Zhang S.; Ba Y.; Bai Y.; Fan N.; Tsuji A.; KUN-HUEI YEH; Ma B.; Wei V.; Shi D.; Magherini E.; Shen L. |
| 臺大學術典藏 |
2021-01-28T01:06:18Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Kun-Huei Yeh; Chen K.-H.; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:18Z |
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.;Wu M.-S.;Kun-Huei Yeh;Lin C.-W.;Hsu P.-N.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Wu M.-S.; KUN-HUEI YEH; Lin C.-W.; Hsu P.-N.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:18Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: A JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
|
Muro K.;Lordick F.;Tsushima T.;Pentheroudakis G.;Baba E.;Lu Z.;Cho B.C.;Nor I.M.;Ng M.;Chen L.-T.;Kato K.;Li J.;Ryu M.-H.;Wan Zamaniah W.I.;Yong W.-P.;Kun-Huei Yeh;Nakajima T.E.;Shitara K.;Kawakami H.;Narita Y.;Yoshino T.;Van Cutsem E.;Martinelli E.;Smyth E.C.;Arnold D.;Minami H.;Tabernero J.;Douillard J.-Y.; Muro K.; Lordick F.; Tsushima T.; Pentheroudakis G.; Baba E.; Lu Z.; Cho B.C.; Nor I.M.; Ng M.; Chen L.-T.; Kato K.; Li J.; Ryu M.-H.; Wan Zamaniah W.I.; Yong W.-P.; KUN-HUEI YEH; Nakajima T.E.; Shitara K.; Kawakami H.; Narita Y.; Yoshino T.; Van Cutsem E.; Martinelli E.; Smyth E.C.; Arnold D.; Minami H.; Tabernero J.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:17Z |
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
|
Satoh T.; Kang Y.-K.; Chao Y.; Ryu M.-H.; Kato K.; Cheol Chung H.; Chen J.-S.; Muro K.; Ki Kang W.; KUN-HUEI YEH; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Tanimoto M.; Chen L.-T.; Boku N. |
| 臺大學術典藏 |
2021-01-28T01:06:17Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Kun-Huei Yeh;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; KUN-HUEI YEH; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:16Z |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
|
Chen L.-T.;Satoh T.;Ryu M.-H.;Chao Y.;Kato K.;Chung H.C.;Chen J.-S.;Muro K.;Kang W.K.;Kun-Huei Yeh;Yoshikawa T.;Oh S.C.;Bai L.-Y.;Tamura T.;Lee K.-W.;Hamamoto Y.;Kim J.G.;Chin K.;Oh D.-Y.;Minashi K.;Cho J.Y.;Tsuda M.;Sameshima H.;Kang Y.-K.;Boku N.; Chen L.-T.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Kang Y.-K.; Boku N. |
| 臺大學術典藏 |
2021-01-28T01:06:16Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
Yang S.-H.;Guo J.-C.;Hsu C.;Kuo S.-H.;Tien Y.-W.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:16Z |
Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver
|
Ho T.-C.; Wang E.-Y.; KUN-HUEI YEH; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; Hsu C.-L.; Chen P.-J.; Yeh S.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
|
Yoshino T.; Pentheroudakis G.; Mishima S.; Overman M.J.; KUN-HUEI YEH; Baba E.; Naito Y.; Calvo F.; Saxena A.; Chen L.-T.; Takeda M.; Cervantes A.; Taniguchi H.; Yoshida K.; Kodera Y.; Kitagawa Y.; Tabernero J.; Burris H.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.;Tai J.J.;Chen L.-T.;Wu M.-S.;Kun-Huei Yeh;Lin C.-W.;Wang T.-E.;Wang H.-P.;Yu F.-J.;Liou J.-M.;Hsiao C.-F.;Cheng T.-Y.;Yeh H.-J.;Ko C.-W.;Chen M.-J.;Lo G.-H.;Hsu P.-I.;Chang C.-S.;Hwang W.-S.;Chuang S.-S.;Lee H.-W.;Shun C.-T.;Chiu C.-F.;Wang W.-M.;Hsieh C.-Y.;Liu T.-W.;Lin J.-T.;Kuo S.-H.;Cheng A.-L.; Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; KUN-HUEI YEH; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need
|
Rau K.-M.;Rau K.-M.;Shun S.-C.;Chiou T.-J.;Lu C.-H.;Lu C.-H.;Ko W.-H.;Ko W.-H.;Lee M.-Y.;Huang W.-T.;Kun-Huei Yeh;Chang C.-S.;Chang C.-S.;Hsieh R.-K.; Rau K.-M.; Rau K.-M.; Shun S.-C.; Chiou T.-J.; Lu C.-H.; Lu C.-H.; Ko W.-H.; Ko W.-H.; Lee M.-Y.; Huang W.-T.; KUN-HUEI YEH; Chang C.-S.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
|
Xu J.; Xu R.-H.; Qin S.; Pan H.; Bai Y.; Chi Y.; Wang L.; Bi F.; Cheng Y.; Liu T.; Ma D.; Shen L.; Ba Y.; Liang J.; Wang X.; Yau T.C.C.; Ma B.B.; KUN-HUEI YEH; Lin J.-K.; Kappeler C.; Shapiro J.; Kalmus J.; Li J. |
| 臺大學術典藏 |
2021-01-28T01:06:14Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Ma W.-L.;Kun-Huei Yeh;Yao M.;Tang J.-L.;Lin C.-W.;Wang Y.-T.;Yeh Y.-C.;Wang H.-P.;Cheng A.-L.;Kuo S.-H.; Ma W.-L.; KUN-HUEI YEH; Yao M.; Tang J.-L.; Lin C.-W.; Wang Y.-T.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:14Z |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
Kun-Huei Yeh;Yang T.-S.;Hsu T.-C.;Tzu-Liang Chen W.;Chen H.-H.;Teng H.-W.;Lin B.-W.;Kuan F.-C.;Chiang F.-F.;Duann C.-W.;Li Y.-S.;Lin M.-T.;Fiala-Buskies S.;Ducreux M.;Wang J.-Y.; KUN-HUEI YEH; Yang T.-S.; Hsu T.-C.; Tzu-Liang Chen W.; Chen H.-H.; Teng H.-W.; Lin B.-W.; Kuan F.-C.; Chiang F.-F.; Duann C.-W.; Li Y.-S.; Lin M.-T.; Fiala-Buskies S.; Ducreux M.; Wang J.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:13Z |
A Pilot Study of Metabolomic Pathways Associated With Fatigue in Survivors of Colorectal Cancer
|
Chou Y.-J.;Kober K.M.;Kuo C.-H.;Kun-Huei Yeh;Kuo T.-C.;Tseng Y.J.;Miaskowski C.;Liang J.-T.;Shun S.-C.; Chou Y.-J.; Kober K.M.; Kuo C.-H.; KUN-HUEI YEH; Kuo T.-C.; Tseng Y.J.; Miaskowski C.; Liang J.-T.; Shun S.-C. |
| 臺大學術典藏 |
2021-01-18T09:12:10Z |
Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
|
KUN-HUEI YEH; Yang, Tsai Sheng; Hsu, Tzu Chi; Tzu-Liang Chen, William; Chen, Hong Hwa; Teng, Hao Wei; Lin, Bo Wen; Kuan, Feng Che; Chiang, Feng Fan; Duann, Chi Wei; Li, Ying Shiuan; Lin, Meng Ting; Fiala-Buskies, Sabine; Ducreux, Michel; Wang, Jaw Yuan |
| 臺大學術典藏 |
2020-02-20T06:52:59Z |
Recent Advances in Systemic Therapy for Advanced Pancreatic Cancer
|
SHIH-HUNG YANG; WEI-CHIH LIAO; YU-WEN TIEN; KUN-HUEI YEH |
| 臺大學術典藏 |
2019-08-05T08:19:51Z |
Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
|
ANN-LII CHENG;Chen, Li-Tzong;PING-NING HSU;CHUNG-WU LIN;KUN-HUEI YEH;MING-SHIANG WU;SUNG-HSIN KUO; SUNG-HSIN KUO; MING-SHIANG WU; KUN-HUEI YEH; CHUNG-WU LIN; PING-NING HSU; Chen, Li-Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:56:05Z |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
|
ANN-LII CHENG;Chen, Li-Tzong;PING-NING HSU;MING-SHIANG WU;CHIA-TUNG SHUN;Wei, Ming-Feng;Lee, Hsiao-Wei;KUN-HUEI YEH;CHUNG-WU LIN;Tsai, Hui-Jen;SUNG-HSIN KUO; SUNG-HSIN KUO; Tsai, Hui-Jen; CHUNG-WU LIN; KUN-HUEI YEH; Lee, Hsiao-Wei; Wei, Ming-Feng; CHIA-TUNG SHUN; MING-SHIANG WU; PING-NING HSU; Chen, Li-Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:55:01Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
ANN-LII CHENG;PING-NING HSU;MING-SHIANG WU;JYH-MING LIOU;Tzeng, Yi-Shin;CHIA-TUNG SHUN;KUN-HUEI YEH;CHUNG-WU LIN;Chen, Li-Tzong;SUNG-HSIN KUO; SUNG-HSIN KUO; Chen, Li-Tzong; CHUNG-WU LIN; KUN-HUEI YEH; CHIA-TUNG SHUN; Tzeng, Yi-Shin; JYH-MING LIOU; MING-SHIANG WU; PING-NING HSU; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:38:07Z |
Helicobacter pylori CagA Translocation Is Closely Associated With the Expression of CagA-signaling Molecules in Low-grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma
|
ANN-LII CHENG;Tzeng, Yi-Shin;Tsai, Hui-Jen;JYH-MING LIOU;MING-SHIANG WU;PING-NING HSU;CHUNG-WU LIN;Chen, Li-Tzong;KUN-HUEI YEH;SUNG-HSIN KUO; SUNG-HSIN KUO; KUN-HUEI YEH; Chen, Li-Tzong; CHUNG-WU LIN; PING-NING HSU; MING-SHIANG WU; JYH-MING LIOU; Tsai, Hui-Jen; Tzeng, Yi-Shin; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:12:47Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
ANN-LII CHENG;Chen, Li-Tzong;HSIU-PO WANG;PING-NING HSU;CHUNG-WU LIN;MING-SHIANG WU;KUN-HUEI YEH;SUNG-HSIN KUO; SUNG-HSIN KUO; KUN-HUEI YEH; MING-SHIANG WU; CHUNG-WU LIN; PING-NING HSU; HSIU-PO WANG; Chen, Li-Tzong; ANN-LII CHENG |
| 臺大學術典藏 |
2019-08-05T07:10:39Z |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma
|
KUN-HUEI YEH; Tsai, Hui-Jen; Chen, Li-Tzong; ANN-LII CHENG; ANN-LII CHENG;Chen, Li-Tzong;Tsai, Hui-Jen;KUN-HUEI YEH;Jeng, Huei-Jiuan;CHUNG-WU LIN;MING-SHIANG WU;PING-NING HSU;Chen, Zi-Hua;Weng, Wen-Hui;SUNG-HSIN KUO; SUNG-HSIN KUO; Weng, Wen-Hui; Chen, Zi-Hua; PING-NING HSU; MING-SHIANG WU; CHUNG-WU LIN; Jeng, Huei-Jiuan |
| 臺大學術典藏 |
2019-08-05T06:59:55Z |
Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma
|
ANN-LII CHENG; ANN-LII CHENG;Lin, Jaw-Town;PING-NING HSU;Chen, Jing-Yi;Tzeng, Yi-Shin;KUN-HUEI YEH;CHUNG-WU LIN;MING-SHIANG WU;Chen, Li-Tzong;Yeh, Pei-Yen;SUNG-HSIN KUO; SUNG-HSIN KUO; Yeh, Pei-Yen; Chen, Li-Tzong; MING-SHIANG WU; CHUNG-WU LIN; KUN-HUEI YEH; Tzeng, Yi-Shin; Chen, Jing-Yi; PING-NING HSU; Lin, Jaw-Town |
| 臺大學術典藏 |
2019-08-05T06:38:53Z |
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment
|
Tzeng, Yi-Shin; HSIU-PO WANG; PING-NING HSU; Lin, Jaw-Town; ANN-LII CHENG; ANN-LII CHENG;Lin, Jaw-Town;PING-NING HSU;HSIU-PO WANG;Tzeng, Yi-Shin;Yeh, Pei-Yen;KUAN-TING KUO;KUN-HUEI YEH;CHUNG-WU LIN;MING-SHIANG WU;Chen, Li-Tzong;SUNG-HSIN KUO; SUNG-HSIN KUO; Chen, Li-Tzong; MING-SHIANG WU; CHUNG-WU LIN; KUN-HUEI YEH; KUAN-TING KUO; Yeh, Pei-Yen |
| 臺大學術典藏 |
2019-04-24T02:25:03Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen, Kuo-Hsing;Yu-Lin Lin;Jau-Yu Liau;Tsai, Jia-Huei;Li-Hui Tseng;Liang-In Lin;Jin-Tung Liang;Been-Ren Lin;Ji-Shiang Hung;Yih-Leong Chang;Kun-Huei Yeh;Ann-Lii Cheng; Chen, Kuo-Hsing; YU-LIN LIN; JAU-YU LIAU; Tsai, Jia-Huei; LI-HUI TSENG; LIANG-IN LIN; JIN-TUNG LIANG; BEEN-REN LIN; JI-SHIANG HUNG; YIH-LEONG CHANG; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T15:22:36Z |
Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma
|
Li, C.-L. and Yeh, K.-H. and Liu, W.-H. and Chen, C.-L. and Chen, D.-S. and Chen, P.-J. and Yeh, S.-H.; Li, Chiao-Ling;Yeh, Kun-Huei;Liu, Wan-Hsin;Chen, Chi-Ling;Chen, Ding-Shinn;Chen, Pei-Jer;Yeh, Shiou-Hwei; 陳定信;葉坤輝;葉秀慧;陳培哲;陳祈玲; Li, Chiao-Ling; Li, Chiao-Ling; PEI-JER CHEN; Yeh, Kun-Huei; Yeh, Kun-Huei; KUN-HUEI YEH; Liu, Wan-Hsin; DING-SHINN CHEN; Liu, Wan-Hsin; SHIOU-HWEI YEH; Chen, Chi-Ling; Chen, Ding-Shinn; Chen, Ding-Shinn; Chen, Pei-Jer; Chen, Pei-Jer; Yeh, Shiou-Hwei; Yeh, Shiou-Hwei; 陳祈玲 |
| 臺大學術典藏 |
2018-09-10T15:17:40Z |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Li, J. and Qin, S. and Xu, R. and Yau, T.C.C. and Ma, B. and Pan, H. and Xu, J. and Bai, Y. and Chi, Y. and Wang, L. and Yeh, K.-H. and Bi, F. and Cheng, Y. and Le, A.T. and Lin, J.-K. and Liu, T. and Ma, D. and Kappeler, C. and Kalmus, J. and Kim, T.W.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T15:17:40Z |
Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang, T.C. and Shiah, H.S. and Yang, C.H. and Yeh, K.H. and Cheng, A.L. and Shen, B.N. and Wang, Y.W. and Yeh, C.G. and Chiang, N.J. and Chang, J.Y. and Chen, L.T.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T14:58:15Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
ANN-LII CHENG; Chang, Yih-Leong; Chang, Yih-Leong; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; LI-HUI TSENG; Lin, Yu-Lin; Liang, Yi-Hsin; Liang, Yi-Hsin; YIH-LEONG CHANG; Jin-Tung Liang; Chang, Jui-Hsing; Tsai, Jia-Huei; Liau, Jau-Yu; BEEN-REN LIN; JAU-YU LIAU; Liang, Jin-Tung; Lin, Been-Ren; LIANG-IN LIN; Lin, Been-Ren; Hung, Ji-Shiang; KUN-HUEI YEH; Ji-Shiang Hung; Lin, Liang-In; Tseng, Li-Hui; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅 |
| 臺大學術典藏 |
2018-09-10T14:52:06Z |
Molecular-targeted therapy for chemotherapy-refractory gastric cancer: A case report and literature review
|
Kuo, H.-Y. and Yeh, K.-H.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T14:52:06Z |
Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN - A randomized, phase III study
|
KUN-HUEI YEH; Satoh, T. and Doi, T. and Ohtsu, A. and Tsuji, A. and Omuro, Y. and Mukaiyama, A. and Kobayashi, M. and Miwa, H. and Xu, R.-H. and Sun, G.-P. and Xu, J.-M. and Wang, J.-W. and Li, J. and Qin, S.-K. and Feng, J.-F. and Chung, H.C. and Bang, Y.-J. and Chung, I.-J. and Yeh, K.-H. |
| 臺大學術典藏 |
2018-09-10T14:50:09Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, Y.-C. and Li, C.-P. and Yen, C.-J. and Hsu, C. and Lin, Y.-L. and Lin, Z.-Z. and Chen, L.-T. and Su, W.-C. and Chao, Y. and Yeh, K.-H. and Cheng, A.-L.; Shen, Ying-Chun;Li, Chung-Pin;Yen, Chia-Jui;Hsu, Chiun;Lin, Yu-Lin;Lin, Zhong-Zhe;Chen, Li-Tzong;Su, Wu-Chou;Chao, Yee;Yeh, Kun-Huei;Cheng, Ann-Lii; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; KUN-HUEI YEH; Shen, Ying-Chun; Shen, Ying-Chun; Li, Chung-Pin; YU-LIN LIN; Li, Chung-Pin; Yen, Chia-Jui; ANN-LII CHENG; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Yu-Lin; Lin, Zhong-Zhe; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T14:49:14Z |
Unmet supportive care needs of patients with colorectal cancer: Significant differences by type D personality
|
Shun, Shiow-Ching;Yeh, Kun-Huei;Liang, Jin-Tung;Huang, John;Chen, Shing-Chia;Lin, Been-Ren;Lee, Pei-Hsuan;Lai, Yeur-Hur; SHIOW-CHING SHUN; Shun, Shiow-Ching; Yeh, Kun-Huei; Jin-Tung Liang; Liang, Jin-Tung; SHING-CHIA CHEN; BEEN-REN LIN; Huang, John; Chen, Shing-Chia; KUN-HUEI YEH; Lin, Been-Ren; YEUR-HUR LAI; Lee, Pei-Hsuan; Lai, Yeur-Hur; 陳杏佳;李姵萱;孫秀卿;賴裕和;林本仁;黃約翰; Shun, S.-C. and Yeh, K.-H. and Liang, J.-T. and Huang, J. and Chen, S.-C. and Lin, B.-R. and Lee, P.-H. and Lai, Y.-H. |
| 臺大學術典藏 |
2018-09-10T09:48:26Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Tseng, Li-Hui;Lin, Liang-In;Liang, Jin-Tung;Lin, Ben-Ren;Hung, Ji-Shiang;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Tseng, L.-H. and Lin, L.-I. and Liang, J.-T. and Lin, B.-R. and Hung, J.-S. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;尤善琦;洪基翔;林本仁;廖肇裕;梁金銅; Lin, Yu-Lin; LI-HUI TSENG; Wang, Yu-Jen; YIH-LEONG CHANG; Huang, Chao-Yuan; Liau, Jau-Yu; Jin-Tung Liang; Hou, Wei-Hsien; Yu, Shan-Chi; Tseng, Li-Hui; JAU-YU LIAU; Wang, Chia-Chun; Lin, Liang-In; Lan, Keng-Hsueh; LIANG-IN LIN; Liang, Jin-Tung; Yu, Hong-Jen; KUN-HUEI YEH; Ji-Shiang Hung; Lin, Ben-Ren; Lai, Ming-Kuen; Hung, Ji-Shiang; YU-LIN LIN; Liu, Shihh-Ping; Pu, Yeong-Shau; Chang, Yih-Leong; ANN-LII CHENG; Cheng, Jason Chia-Hsien; Yeh, Kun-Huei; Cheng, Ann-Lii; 蒲永孝; 余宏政; 成佳憲; 王嘉檇; 賴明坤; 黃昭淵; 劉詩彬; 藍耿學 |
| 臺大學術典藏 |
2018-09-10T09:42:02Z |
Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 study
|
Ohtsu, A. and Ajani, J.A. and Bai, Y.-X. and Bang, Y.-J. and Chung, H.-C. and Pan, H.-M. and Sahmoud, T. and Shen, L. and Yeh, K.-H. and Chin, K. and Muro, K. and Kim, Y.H. and Ferry, D. and Tebbutt, N.C. and Al-Batran, S.-E. and Smith, H. and Costantini, C. and Rizvi, S. and Lebwohl, D. and Van Cutsem, E.; KUN-HUEI YEH |
| 臺大學術典藏 |
2018-09-10T09:42:02Z |
Erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)
|
Hsu, C.;Shen, Y.-C.;Cheng, C.-C.;Cheng, A.-L.;Hu, F.-C.;Yeh, K.-H.; KUN-HUEI YEH; ANN-LII CHENG |
